QCD Approach to B->D \pi Decays and CP Violation

The branching ratios and CP violations of the $B\to D\pi$ decays, including both the color-allowed and the color-suppressed modes, are investigated in detail within QCD framework by considering all diagrams which lead to three effective currents of two quarks. An intrinsic mass scale as a dynamical gluon mass is introduced to treat the infrared divergence caused by the soft collinear approximation in the endpoint regions, and the Cutkosky rule is adopted to deal with a physical-region singularity of the on mass-shell quark propagators. When the dynamical gluon mass $\mu_g$ is regarded as a universal scale, it is extracted to be around $\mu_g = 440$ MeV from one of the well-measured $B\to D\pi$ decay modes. The resulting predictions for all branching ratios are in agreement with the current experimental measurements. As these decays have no penguin contributions, there are no direct $CP$ asymmetries. Due to interference between the Cabibbo-suppressed and the Cabibbo-favored amplitudes, mixing-induced CP violations are predicted in the $B\to D^{\pm}\pi^{\mp}$ decays to be consistent with the experimental data at 1-$\sigma$ level. More precise measurements will be helpful to extract weak angle $2\beta+\gamma$.Comment: 21pages,5 figures,3 tables, typos corrected and numerical result for one of decay channels is improve

Two Photon Radiation in W and Z Boson Production at the Tevatron Collider

We present a calculation of two photon radiation in W and Z boson production in hadronic collisions, based on the complete matrix elements for the processes q\bar q'\to\ell^\pm\nu\gamma\gamma and q\bar q\to\ell^+\ell^-\gamma\gamma, including finite charged lepton masses. In order to achieve stable numerical results over the full phase space, multiconfiguration Monte Carlo techniques are used to map the peaks in the differential cross section. Numerical results are presented for the Fermilab Tevatron.Comment: Revtex, 28 pages, 3 figure

Role of electromagnetic dipole operator in the electroweak penguin dominated vector meson decays of BB meson

The pure annihilation type decays $B^0_d\to\phi\gamma$ and $B_s\to\rho\gamma$ receive only color suppressed penguin contributions with a very small branching ratio in the standard model. When we include the previously neglected electromagnetic dipole operator, the branching ratios can be enhanced one order magnitude larger than previous study using QCD factorization approach. That is ${\cal BR}(\bar B^0_d\to\phi\gamma)\simeq 1 \times 10^{-11}$ and ${\cal BR}(B_s\to\rho\gamma) \sim (6-16)\times 10^{-10}$. The new effect can also give a large contribution, of order $10^{-9}$, to transverse polarization of $B\to\phi\rho$ and $B\to \omega\phi$ which is comparable to the longitudinal part. These effects can be detected in the LHCb experiment and the Super-B factories.Comment: Revised extensively. 8 pages, 4 figure

Charmless hadronic Bc→VA,AAB_c \to VA, AA decays in the perturbative QCD approach

In this work, we calculate the branching ratios (BRs) and the polarization fractions of sixty two charmless two-body $B_c$ meson decays into final states involving one vector and one axial-vector meson ($VA$) or two axial-vector mesons($AA$) within the framework of perturbative QCD (pQCD) approach systematically, where $A$ is either a $^3P_1$ or $^1P_1$ axial-vector meson. All considered decay channels can only occur through the annihilation topologies in the standard model. Based on the perturbative calculations and phenomenological analysis, we find the following results: (i) the CP-averaged BRs of the considered sixty two $B_c$ decays are in the range of $10^{-5}$ to $10^{-9}$; (ii) since the behavior for $^1P_1$ meson is much different from that of $^3P_1$ meson, the BRs of $B_c \to A(^1P_1) (V, A(^1P_1))$ decays are generally larger than that of $B_c \to A(^3P_1) (V, A(^3P_1))$ decays in the pQCD approach; (iii) many considered decays modes, such as $B_c\to a_1(1260)^+ \omega$, $b_1(1235) \rho$, etc, have sizable BRs within the reach of the LHCb experiments; (iv) the longitudinal polarization fractions of most considered decays are large and play the dominant role; (v) the pQCD predictions for several decays involving mixtures of $^3P_1$ and/or $^1P_1$ mesons are highly sensitive to the values of the mixing angles, which will be tested by the ongoing LHC and forthcoming Super-B experiments; (vi) the CP-violating asymmetries of these considered $B_c$ decays are absent in the standard model because only one type tree operator is involved.Comment: 31 pages, 1 figur

Recent developments in radiative B decays

We report on recent theoretical progress in radiative B decays. We focus on a calculation of logarithmically enhanced QED corrections to the branching ratio and forward-backward asymmetry in the inclusive rare decay anti-B --> X(s) l+ l-, and present the results of a detailed phenomenological analysis. We also report on the calculation of NNLO QCD corrections to the inclusive decay anti-B --> X(s) gamma. As far as exclusive modes are concerned we consider transversity amplitudes and the impact of right-handed currents in the exclusive anti-B --> K^* l+ l- decay. Finally, we state results for exclusive B --> V gamma decays, notably the time-dependent CP-asymmetry in the exclusive B --> K^* gamma decay and its potential to serve as a so-called ``null test'' of the Standard Model, and the extraction of CKM and unitarity triangle parameters from B --> (rho,omega) gamma and B --> K^* gamma decays.Comment: 5 pages, 2 figures. Accepted for publication in the proceedings of International Europhysics Conference on High Energy Physics (EPS-HEP2007), Manchester, England, 19-25 Jul 200

P216 Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)

Abstract Background C-reactive protein (CRP) is widely used as a biomarker of inflammatory disease activity in hospitalized and non-hospitalized patients. In particular, CRP is commonly used in patients suspected to have an inflammatory bowel disease (IBD) or with a confirmed diagnosis of IBD diagnosis in order to drive the diagnostic approach, to monitor disease activity and to guide therapeutic adjustments. However, standard laboratory CRP testing (Immunonephelometric assays) present some drawbacks, including a turnaround time of 1–2 hours, and the need of specialized equipment, offices and laboratory personnel. Because of that, point-of care testing (POCT) was recently developed in order to provide results within 2 minutes from blood collection, enabling a rapid response to clinical condition. Aim To determine the degree of analytical correlation between a recently developed POCT (ProciseDx) using capillary whole blood and the comparative Immunonephelometric assay using serum samples. Methods From October to November 2020, consecutive patients hospitalized at Gastroenterology Unit, Padua University Hospital, aged > 18 years and with clinical evidence of active inflammatory disease or infection, who underwent to a standard of care CRP test (Dimension Vista – Siemens Healthineers) were included in the study (range 2.9–340 g/L). Within 1 hour from blood collection, in each patient, CRP quantitation from capillary whole blood collected by finger stick was performed using the ProciseDx CRP assay, with reportable range between 3.6–100 g/L. A Deming regression test was used to identify the correlation between the two methods. Results Eighty-three patients were enrolled (62.5% males with mean age ± SD: 60±18). The most common indications for hospitalisation were liver disease (34.9%), pancreatic disturbance (27.7%) and suspicious or recurrence of IBD (16.7%). ProciseDx POCT with finger prick samples required a turnaround time of 2±0.2 minutes, whereas serum samples analyzed in clinical laboratory with the reference method required a turnaround time of about 180±15 minutes (p<0.001). Overall, the correlation between the two tests was high (R squared of 0.899 (95% CI 0.916–0.968)). In particular, the correlation between the methods was even higher with CRP values between 0–100 g/L with R squared of 0.961 (95% CI 0.958–0.986). Conclusion The ProciseDx POCT allows a more rapid and comparable accuracy of CRP assessment in hospitalized patients as compared to the standard laboratory measurement. Moreover, the ProciseDx POCT does not require specialised personnel to be performed. The use of ProciseDx POCT may improve and accelerate the decision-making approach, further reducing the resources required for CRP assessment

Fast shower simulation in the ATLAS calorimeter

The time to simulate pp collisions in the ATLAS detector is largely dominated by the showering of electromagnetic particles in the heavy parts of the detector, especially the electromagnetic barrel and endcap calorimeters. Two procedures have been developed to accelerate the processing time of electromagnetic particles in these regions: (1) a fast shower parameterisation and (2) a frozen shower library. Both work by generating the response of the calorimeter to electrons and positrons with Geant 4, and then reintroduce the response into the simulation at runtime. In the fast shower parameterisation technique, a parameterisation is tuned to single electrons and used later by simulation. In the frozen shower technique, actual showers from low-energy particles are used in the simulation. Full Geant 4 simulation is used to develop showers down to ~1 GeV, at which point the shower is terminated by substituting a frozen shower. Judicious use of both techniques over the entire electromagnetic portion of the ATLAS calorimeter produces an important improvement of CPU time. We discuss the algorithms and their performance in this paper

Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 12 months of longitudinal follow‐up

Background Little is known about the natural history and impact of irritable bowel syndrome (IBS)-type symptoms on psychological health and quality of life in inflammatory bowel disease (IBD). We aimed to address this in a 12-month longitudinal follow-up study of secondary care patients. Methods We collected demographic, Rome III IBS-type symptom, psychological, and quality of life data, with questionnaires at 3-month intervals, over 12 months of follow-up in patients with IBD in clinical remission at baseline. We assessed the natural history of Rome III IBS-type symptoms over the 12 months of the study and compared psychological and quality of life data between those reporting Rome III IBS-type symptoms at each of the points of follow-up with those not reporting such symptoms. Key Results Among 206 patients with IBD in clinical remission at baseline (104 [50.5%] women, mean age 56.9 years [range 18–83 years], 79 [38.3%] Crohn's disease), 33 (16.0%) reported Rome III IBS-type symptoms at baseline and 72 (35.0%) reported Rome III IBS-type symptoms at one or more time points. Among the 33 patients with Rome III IBS-type symptoms at baseline, symptoms resolved in 6 (18.2%) patients, were present throughout in 6 (18.2%) patients, and fluctuated in the remaining 21 (63.6%) patients. Among the 39 patients with new onset of Rome III IBS-type symptoms after baseline, 24 (65.1%) had symptoms at one point in time only, 10 (25.6%) at two points, four (10.3%) at three points, and one (2.6%) at four points. At each point in time, reporting IBS-type symptoms was associated with significantly higher anxiety, depression, or somatoform symptom-reporting scores, and/or lower quality of life scores. Conclusions & Inferences In this 12-month follow-up study, one-third of patients with IBD reported presence of Rome III IBS-type symptoms at any point in time. Reporting such symptoms was associated with significant impacts on psychological health and/or quality of life